Zoetis

YTD

ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments.

CEO

Kristin C. Peck

CEOKristin C. Peck

Employees

14,500

Employees14,500

Headquarters

Parsippany, New Jersey

HeadquartersParsippany, New Jersey

Founded

1952

Founded1952

Employees

14,500

Employees14,500

ZTS Key Statistics

Market cap

31.88B

Market cap31.88B

Price-Earnings ratio

12.89

Price-Earnings ratio12.89

Dividend yield

2.65%

Dividend yield2.65%

Average volume

8.04M

Average volume8.04M

High today

$77.59

High today$77.59

Low today

$75.55

Low today$75.55

Open price

$76.64

Open price$76.64

Volume

15.72M

Volume15.72M

52 Week high

$161.77

52 Week high$161.77

52 Week low

$72.38

52 Week low$72.38

Stock Snapshot

With a market cap of 31.88B, Zoetis(ZTS) trades at $76.50. The stock has a price-to-earnings ratio of 12.89 and currently yields dividends of 2.65%.

During the trading session on 2026-06-27, Zoetis(ZTS) shares reached a daily high of $77.59 and a low of $75.55. At a current price of $76.50, the stock is +1.3% higher than the low and still -1.4% under the high.

Trading activity shows a volume of 15.72M, compared to an average daily volume of 8.04M.

Over the past 52 weeks, Zoetis(ZTS) stock has traded between a high of $161.77 and a low of $72.38.

ZTS News

MarketWatch 10h

Zoetis Inc. stock underperforms Friday when compared to competitors - MarketWatch

...

TipRanks 20h

Zoetis price target lowered to $85 from $95 at Stifel

Stifel lowered the firm’s price target on Zoetis (ZTS) to $85 from $95 and keeps a Hold rating on the shares. After atopic dermatitis checks in international ma...

Simply Wall St 21h

Should Investor Lawsuits Over Safety, Competition, and Demand Disclosures Reshape How Zoetis Is Viewed?

In the past year, multiple law firms filed securities class action lawsuits against Zoetis, alleging that management issued misleading statements about competit...

Analyst ratings

55%

of 20 ratings

Buy

55%

Hold

45%

Sell

More ZTS News

The Motley Fool 5d

The Best Stocks to Invest $1,000 in Right Now

Long-term investing is about building your portfolio brick by brick. That could mean adding money weekly, monthly, or whenever you have extra cash on hand. How...

Simply Wall St 6d

Zoetis Stock Could Be 15.3% Undervalued After Class Action Lawsuits

Zoetis (ZTS) is back in focus after a series of securities class action lawsuits accused the company of misleading investors about weakening demand, safety conc...

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.